Integration: Gospel for immune bioinformatician on epitope-based therapy
- 1Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi’an, Shaanxi, China
- 2The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi’an, Shaanxi, China
- 3Department of Microbiology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi’an, Shaanxi, China
- 4Department of Rheumatology, Tangdu Hospital, Air-Force Medical University (the Fourth Military Medical University), Xi’an, Shaanxi, China
A Corrigendum on
Integration: gospel for immune bioinformatician on epitope-based therapy
by Sun B, Zhang J, Li Z, Xie M, Luo C, Wang Y, Chen L, Wang Y, Jiang D and Yang K (2023). Front. Immunol. 14:1075419. doi: 10.3389/fimmu.2023.1075419
In the published article, there were two errors in the Graphical Abstract as published. In the top right-hand corner of the image, under the “CD8 + T cell” section, “CD4” should read “CD8” and on the left-hand side of the image, “Conversation” should read “Conservation”. The corrected Graphical Abstract appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: integration, epitope, immunotherapy, in silico, bioinformatics, immune response
Citation: Sun B, Zhang J, Li Z, Xie M, Luo C, Wang Y, Chen L, Wang Y, Jiang D and Yang K (2023) Corrigendum: Integration: gospel for immune bioinformatician on epitope-based therapy. Front. Immunol. 14:1214876. doi: 10.3389/fimmu.2023.1214876
Received: 30 April 2023; Accepted: 18 May 2023;
Published: 24 May 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Sun, Zhang, Li, Xie, Luo, Wang, Chen, Wang, Jiang and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Dongbo Jiang, c3VwZXJqYW1lczE5OTFAZm94bWFpbC5jb20=; Kun Yang, eWFuZ2t1bmt1bkBmbW11LmVkdS5jbg==
†These authors share first authorship